4
Changes in Ownership
Gain Therapeutics, Inc. Filed Acc 0001209191-23-051502
Chief Executive Officer acquired 825 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alder Matthias Chief Executive Officer | 2023-10-01 | Option exercise | +825 | 6,675 | D | ||
| Derivatives | |||||||
| Alder Matthias Chief Executive Officer | 2023-10-01 | Option exercise · Restricted Stock Units | −825 | 9,075 | D | ||
Loading xslF345X05/doc4.xml…